Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2001
04/18/2001EP1091744A1 1-octadecyl-2-methyl-sn-glycero-3-phosphocholine (et180ch3) for the treatment of human carcinoma of the breast
04/18/2001EP1091743A1 Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury
04/18/2001EP1091742A1 Indium photosensitizers for pdt
04/18/2001EP1091741A1 Azepine derivatives having effects on serotonin related systems
04/18/2001EP1091740A1 Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
04/18/2001EP1091739A1 Method for inhibiting c-jun expression using jak-3 inhibitors
04/18/2001EP1091738A1 BICYCLIC sPLA 2 INHIBITORS
04/18/2001EP1091737A2 Calcium channel blockers
04/18/2001EP1091736A1 Inhibitors of prenyl-protein transferase
04/18/2001EP1091735A1 Application for utility patent for improved enriched platelet wound healant
04/18/2001EP1091734A1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
04/18/2001EP1091733A1 (-)-pseudoephedrine as a sympathomimetic drug
04/18/2001EP1091731A1 Anti-inflammatory pharmaceutical formulations
04/18/2001EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
04/18/2001EP1091659A1 Oral form of administration
04/18/2001EP0935462A4 Photopheresis treatment of leukocytes
04/18/2001EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
04/18/2001EP0874815B1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
04/18/2001EP0843678B1 1,9-diazabicyclo[4.3.0]nona-3,8-diene derivatives
04/18/2001EP0797437B1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNFalpha
04/18/2001EP0771201B1 Use of 2-phenyl-3-aroylbenzothiophenes for the preparation of a medicament for inhibiting primary endometrial hyperplasia
04/18/2001EP0765321B1 2-amino-3-aroyl-benzo beta thiophenes and method of making the same
04/18/2001EP0731697B1 Ssi tyrphostins and pharmaceutical compositions
04/18/2001EP0723544B1 ALKOXY ALKYL CARBAMATES OF IMIDAZO[1,2-a]PYRIDINES
04/18/2001EP0682663B1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections
04/18/2001EP0663832B1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
04/18/2001EP0579827B1 Method of preparing 2-arylbenzimidazole 5-sulphonic acids
04/18/2001EP0568606B1 Microbial oils and uses thereof
04/18/2001EP0546160B1 Method of reversing local anesthesia and reagent system therefor
04/18/2001CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy
04/18/2001CN1291993A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
04/18/2001CN1291990A S-Substituted 11 & Beta-Benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for production thereof and pharmaceutical preparations containing these compounds
04/18/2001CN1291989A Substance having steroid-like structure, process for production thereof and antitumor agents containing same
04/18/2001CN1291988A Novel aromatic amides, preparation method and application as medicines
04/18/2001CN1291984A Glycine transport inhibitors
04/18/2001CN1291983A 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
04/18/2001CN1291982A Nitrate salt of anti-ulcer medicine
04/18/2001CN1291981A Thiophene nitrone compounds
04/18/2001CN1291980A thioether furan nitrone compounds
04/18/2001CN1291979A Novel pyridazine derivatives and drugs containing same as active ingredient
04/18/2001CN1291978A Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists
04/18/2001CN1291977A Amino anthracyclinone derivatives and their use in treatment of amyloidosis
04/18/2001CN1291976A Indole ferivatives and medicinal compositions containing same
04/18/2001CN1291975A Process for preparing protected 4-aminomethyl-pyrrolidin-3-one
04/18/2001CN1291974A Cyclohexanediole derivatives
04/18/2001CN1291972A Novel capsaicinoide-like substances having ester bond
04/18/2001CN1291896A Pharmaceutical compositions for ulcer
04/18/2001CN1291895A Polymeric compounds and methods of formulating same
04/18/2001CN1291894A Compositions comprising D-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
04/18/2001CN1291893A Use of D1/D5 antagonist for treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating desorders, impulse control disorders and autism
04/18/2001CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors
04/18/2001CN1291891A Method for treating COPD
04/18/2001CN1291890A 20-Hete antagonists and agonists
04/18/2001CN1291889A Fluoxetine hydrochloride for decreasing hot flashes
04/18/2001CN1291888A Sustained-release preparation for AII antagonist, production and use thereof
04/18/2001CN1291887A Stable shaped particles of crystalline organic compounds
04/18/2001CN1291886A Formulations
04/18/2001CN1291862A Fungicide composition comprising benzoylphenylurea
04/18/2001CN1291615A 2', 3'-O-isopropylidennucleoside 5'-thiophosphamino acid ester compound
04/18/2001CN1291612A Cynnematin kind antibiotics
04/18/2001CN1291611A Cynnematin kind antibiotics
04/18/2001CN1291610A Triazole derivative possessing anti-fungus activity
04/18/2001CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system
04/18/2001CN1291502A Chinese-medicinal pill for treating gynopathy
04/18/2001CN1291498A Ointment for treating spinal hyperosteogeny
04/18/2001CN1291496A Plaster 'Gucixiao' and its preparing process
04/18/2001CN1291489A Chinese medicine for treating baby pneumonia
04/18/2001CN1291481A Application of konjack and its extract in preparing medicinal composition
04/18/2001CN1291479A Chinese medicine for treating cardiovascular and cerebrovascular diseases
04/18/2001CN1291477A Medicinal composition for treating optical atrophy
04/18/2001CN1291476A Medicine for muscular fatigue
04/18/2001CN1291475A Cell-protecting amifostine and its preparing process
04/18/2001CN1291474A Taxusol-lipid composition and its preparing process
04/18/2001CN1291468A Condensed benzene derivative used as antioxidant or free radical scavenger and its use in cosmetic preparations
04/18/2001CN1064685C Tetrahydrofuran antifungals
04/18/2001CN1064684C Effective components of wild opium poppy and extracting process and product thereof
04/18/2001CN1064681C Heterocyclic compounds
04/18/2001CN1064680C Process for preparing magnesium omeprazole
04/18/2001CN1064676C Ortho-substituted benzoyl guanidine, its preparation, use and medicines containing it
04/18/2001CN1064674C Alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them
04/18/2001CN1064540C Medicine for burn and scald and preparing process
04/18/2001CN1064537C Skin absorptive antiviral drug acyclovir
04/18/2001CN1064533C Compound capsule for treating red swollen and heat evil duo to wind-cold-dampness
04/18/2001CN1064532C Pill for pelvic inflammation and cervical erosion
04/18/2001CN1064531C Process for preparation of injectable ready-to use solution containing antitumor anthracycline glycoside
04/17/2001US6218547 1-phenyl-benzimidazole compounds and their use as GABA-a receptor modulators
04/17/2001US6218544 Heterocyclic esters and amides
04/17/2001US6218539 Phenyl ureas
04/17/2001US6218538 Antagonists of n-type neuronal calcium channels useful in the treatment of cerebrovascular ischaemia and pain.
04/17/2001US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds
04/17/2001US6218528 MurB
04/17/2001US6218526 Polynucleotide encoding human netrin-1
04/17/2001US6218513 Genetically engineered hemoglobins; for used to treat anemia and hemorrhages; for amplification of cells oxygen carrying capabilities
04/17/2001US6218506 Soluble brain protein for the detection, prevention and treatment of alzhiemer's disease
04/17/2001US6218438 N-aroyl hydrazone poly(oxyethylene)-poly(oxypropylene) nonionic block copolymer; hiv
04/17/2001US6218437 Administering a therapeutic amount of di-tert-butylphenol derivative to subject under conditions such that said symptoms are diminished
04/17/2001US6218436 Administering to subject sufficient amount of meso zeaxanthin to increase serum concentration of carotenoids; therapy or prevention of age-related macular degeneration in human subject by increasing deposition of yellow macular pigment
04/17/2001US6218435 Reduction of hair growth
04/17/2001US6218434 Use of the naturally-occurring quinones thymoquinone and dithymoquinone as antineoplastic and cytotoxic agents
04/17/2001US6218433 Administering a suitable pharmaceutical carrier and an effective amount of an active compound selected from the group consisting of phenylacetydroxamic acid, phenoxyacetydroxamic acid, arylacetydroxamic acid and their corresponding amides